Abstract: The present invention relates to new compounds of formula I, a process for their preparation and new intermediates prepared therein, pharmaceutical formulations containing said compounds and to the use of said compounds in therapy.
Type:
Application
Filed:
November 14, 2005
Publication date:
June 8, 2006
Applicants:
AstraZeneca AB, NPS Pharmaceutical
Inventors:
Jalaj Arora, Louise Edwards, Methvin Isaac, Donald McLeod, Abdelmalik Slassi, Tomislav Stefanac, Thomas Stormann, David Wensbo, Tao Xin, Helena Gyback, Martin Johansson, Annika Kers, John Malmberg, Alexander Minidis, Karin Oscarsson, Mangus Waldman, Ulrika Yngve, Christoffer Osterwall